In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

Objective: Ciprofloxacin resistance (CIP(R)) for Shigella isolates is becoming more prevalent. This study systematically investigated the antibacterial activity of ciprofloxacin (CIP)/fosfomycin (FOS) combination in vitro and in vivo against CIP(R) S. flexneri isolates. Method: Eighty CIP(R) S. flex...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Infect Drug Resist
Autors principals: Liu, Yanyan, Li, Hongru, Zhang, Yalong, Ye, Ying, Gao, Yufeng, Li, Jiabin
Format: Artigo
Idioma:Inglês
Publicat: Dove 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6580129/
https://ncbi.nlm.nih.gov/pubmed/31354311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S208071
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars